Aug 2026· Tissue & Cell· Vol 104 Pt 1, pp.
103846
· 0 citations· 212 references
Medicine
TL;DR
Although further study is needed to support the clinical application of i-dMSCs, these results indicate that they have the potential to become the seed cell for stem cell therapy, providing new ideas for the field of regenerative medicine.
Abstract
Dental and surrounding tissues are important sources of mesenchymal stem cells (MSCs), which are the major component of stem cell therapy. In addition to the self-renewal and multi-directional differentiation abilities, the immunoregulatory function of MSCs is of great interest to researchers, which suggests that MSCs can maintain their characteristics and functions in tissues affected by inflammation. This review first discussed the performance changes of inflammatory dental mesenchymal stem cells (i-dMSCs) from both in vivo and in vitro sources, exploring the effects of inflammation on dental mesenchymal stem cells (dMSCs) and the ability of dMSCs to resist the inflammatory microenvironment. Then, we summarized the relevant literature on methods to improve the function of i-dMSCs. Finally, clinical trials related to the preservation of dental and surrounding tissues affected by inflammation were mentioned, demonstrating the presence of functional MSCs in inflammatory tissues. Although further study is needed to support the clinical application of i-dMSCs, these results indicate that they have the potential to become the seed cell for stem cell therapy, providing new ideas for the field of regenerative medicine.
This review critically analyzes the immunoregulatory pathways involved in inflammatory and immune-related disorders, and directly links these mechanisms to the challenges within the tumor microenvironment.
These cells can be isolated from a wide range of human tissues, including bone marrow (BM-MSCs), adipose tissue (AD-MSCs), dental tissues, such as dental pulp stem cells (DPSCs) and periodontal ligament stem cells (PDLSCs), as well as umbilical cord cells (UC-MSCs), including Wharton’s jelly–derived MSCs (UC-MSCs-WJ) a...
Letícia Odaguiri Watanabe, Luana Roleto Cardoso, Johnny Carvalho da Silva et al.· Biogerontology (Dordrecht)· 0 citations
The studies on MSC fusion reviewed here suggest the potential of the resulting hybrids for tissue regeneration, particularly in the cardiovascular, muscular, and nervous systems, however, there is also evidence that spontaneous MSC fusion is a rare event.
T. Burnik, Metka Pirnat, Matjaž Jeras et al.· Cellular & Molecular Bio...· 0 citations
Periodontal disease is a chronic inflammatory condition that destroys the supporting structures of the teeth and is not predictably restored by conventional therapies using mechanical debridement and surgery alone. Dental pulp mesenchymal stem cells represent a relatively accessible and ethically acceptable source of m...
Karina Pratiwi Putri, Rike Rayanti, T. Sumarwoto· Indonesian Journal of Biotec...· 0 citations
This review provides a comprehensive framework for developing safer, standardized, and clinically transformative therapies based on MSCs, and explores emerging strategies to enhance the activity of MSCs, including pretreatment and activation, lifestyle intervention, and genetic engineering techniques.
Dong-Mei Xue, Yong-Sheng Li, Lei Wu· MedComm· 0 citations
Mesenchymal Stem Cells (MSCs) are widely used in regenerative medicine due to their selfrenewal capacity and immunomodulatory functions. Increasing evidence suggests that these same properties influence tumor progression and response to cancer therapy. This review provides a detailed overview of how MSCs can be utilize...
S. Nedunchezhian, Thirunavukkarasu Palaniyandi, H. Surendran et al.· Current pharmaceutical desig...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.